Coverage
-
January 08, 2024
Teva and a group of institutional investors told a Connecticut federal court on Monday that they've agreed to end the shareholders' litigation seeking damages over the pharmaceutical giant's role in America's opioid epidemic, which resulted in a $4.25 billion settlement to resolve thousands of lawsuits against the company.
1 other articles on this case.
View all »